The gut microbiome comprises the trillions of bacteria and other microorganisms that live in our digestive tracts, and it has ...

Dr Annalisa Morgan previews discussions on disease-modifying therapies, emerging treatments such as CAR T-cell therapy, and ...

Merck KGaA’s U.S. pharma arm has recruited actor Selma Blair for a collaboration around multiple sclerosis treatment Mavenclad. | No cruel intentions here: Merck KGaA’s U.S. pharma arm has recruited ...

Maria Trojano describes herself as “a strong-willed person” who has always enjoyed solving problems. For her, neurology seems ...

Building on more than two decades of research, a study by MIT neuroscientists at The Picower Institute for Learning and ...

Columnist Ben Hofmeister explains how songs such as "No One Is to Blame" have become part of the soundtrack of his life with MS.

Four new SPMS patients not eligible for a Tiziana Life Sciences trial were dosed with foralumab nasal spray in an expanded access program.

The U.S. Food and Drug Administration (FDA) has approved vimseltinib (RomvimzaTM) for adult patients with a rare condition called tenosynovial giant cell tumor (TGCT). TGCT is a tumor of the tissue ...